Arch Oncology: Funding, Investors & Team (Oct 2026)
At Arch Oncology, they are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer. They are committed to advancing antibodies with best-in-class potential.Their next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class.
Arch Oncology has raised $105M across 1 funding round on record, the most recent a Series C of $105M announced in Apr 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Arch Oncology Company Profile and Key Stats
Latest funding round on record: Apr 2021.
Arch Oncology Funding Rounds
Arch Oncology Founders and Leadership Team
Contact details for the Arch Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Arch Oncology Funding Compared to Other Biotechnology Startups
Arch Oncology's latest round of $105M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Arch Oncology in Biotechnology and Brisbane
Companies Similar to Arch Oncology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Arch Oncology Funding FAQs
What does Arch Oncology do?
At Arch Oncology, they are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer. They are committed to advancing antibodies with best-in-class potential.Their next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class.
How much funding has Arch Oncology raised?
Arch Oncology has raised $105M across 1 round on record. The most recent is a Series C of $105M announced in Apr 2021.
When did Arch Oncology last raise funding?
Arch Oncology's most recent funding round on record is a Series C of $105M, announced in Apr 2021.
Who is the CEO of Arch Oncology?
Laurence Blumberg is listed as CEO at Arch Oncology.
Where is Arch Oncology headquartered?
Arch Oncology is based in Brisbane, California, United States.
How many employees does Arch Oncology have?
Arch Oncology is in the 11-50 employee band.
How does Arch Oncology's funding compare to other Biotechnology startups?
Arch Oncology's latest round of $105M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Arch Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Arch Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.